Diagnostics & Research
The Diagnostics & Research industry has a total of 51 stocks, with a combined market cap of $787.11 billion, total revenue of $166.43 billion and a weighted average PE ratio of 52.56.
Market Cap
787.11B
Revenue
166.43B
Profits
14.98B
PE Ratio
52.56
Profit Margin
9.00%
Dividend Yield
0.18%
51 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 211.70B | -2.93% | 290,568 | 43.74B |
| 2 | DHR | Danaher Corporation | 158.76B | -1.62% | 505,695 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 57.50B | -0.81% | 29,230 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 41.20B | -2.48% | 357,995 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 36.59B | -5.44% | 429,239 | 15.90B |
| 6 | NTRA | Natera, Inc. | 33.21B | 1.02% | 56,189 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.58B | -2.51% | 9,210 | 3.94B |
| 8 | WAT | Waters Corporation | 23.18B | -2.06% | 52,298 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 21.70B | -1.51% | 77,541 | 13.77B |
| 10 | DGX | Quest Diagnostics Incorporated | 20.47B | 0.76% | 50,056 | 10.85B |
| 11 | ILMN | Illumina, Inc. | 19.23B | -1.65% | 120,122 | 4.29B |
| 12 | EXAS | Exact Sciences Corporation | 19.17B | -0.05% | 1,879,068 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.02B | -7.52% | 78,477 | 2.36B |
| 14 | GH | Guardant Health, Inc. | 13.81B | 1.17% | 291,635 | 902.57M |
| 15 | ICLR | ICON Public Limited Company | 13.48B | -5.96% | 189,979 | 8.10B |
| 16 | RVTY | Revvity, Inc. | 11.38B | -2.78% | 44,298 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 10.13B | -0.23% | 87,808 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 8.86B | -2.53% | 38,984 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 6.10B | -0.43% | 11,836 | 1.97B |
| 20 | SHC | Sotera Health Company | 4.66B | -2.49% | 1,211,495 | 1.15B |
| 21 | WGS | GeneDx Holdings Corp. | 4.66B | 0.44% | 18,336 | 402.19M |
| 22 | BLLN | BillionToOne, Inc. | 4.64B | -0.57% | 12,039 | 209.03M |
| 23 | GRAL | GRAIL, Inc. | 3.91B | -0.95% | 123,512 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.67B | -2.66% | 65,664 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 1.88B | -1.15% | 55,894 | 376.57M |
| 26 | NEO | NeoGenomics, Inc. | 1.55B | -0.91% | 162,001 | 709.16M |
| 27 | NEOG | Neogen Corporation | 1.27B | -1.35% | 141,289 | 886.89M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.14B | -0.79% | 2,678 | 343.53M |
| 29 | OPK | OPKO Health, Inc. | 1.04B | -1.09% | 72,884 | 642.07M |
| 30 | CDNA | CareDx, Inc | 962.05M | -0.77% | 151,789 | 358.00M |
| 31 | PSNL | Personalis, Inc. | 891.60M | -1.28% | 44,231 | 69.10M |
| 32 | FLGT | Fulgent Genetics, Inc. | 869.26M | -1.26% | 17,413 | 315.55M |
| 33 | MYGN | Myriad Genetics, Inc. | 676.27M | -1.02% | 34,429 | 825.30M |
| 34 | BNR | Burning Rock Biotech Limited | 254.09M | 3.74% | 2,340 | 75.75M |
| 35 | PRE | Prenetics Global Limited | 232.23M | -4.10% | 22,974 | 77.08M |
| 36 | MDXH | MDxHealth SA | 177.20M | 0.85% | 15,388 | 103.07M |
| 37 | XGN | Exagen Inc. | 163.40M | -0.96% | 16,309 | 63.60M |
| 38 | IMDX | Insight Molecular Diagnostics Inc. | 151.35M | -1.12% | 932 | 4.40M |
| 39 | FONR | FONAR Corporation | 94.76M | 0.03% | 723 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 66.17M | 2.18% | 382 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 45.55M | 2.36% | 537 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 29.47M | -8.77% | 102,870 | 513.02M |
| 43 | MBAI | Check-Cap Ltd. | 9.60M | -4.09% | 8,926 | - |
| 44 | ADVB | Advanced Biomed Inc. | 8.26M | -2.05% | 2,040 | - |
| 45 | BIAF | bioAffinity Technologies, Inc. | 7.07M | 0.32% | 9,252 | 6.78M |
| 46 | NDRA | ENDRA Life Sciences Inc. | 6.60M | -4.99% | 304,621 | - |
| 47 | PRPH | ProPhase Labs, Inc. | 6.28M | 0.59% | 644,405 | 5.06M |
| 48 | MYNZ | Mainz Biomed N.V. | 6.22M | -0.86% | 5,269 | 659.94K |
| 49 | ISPC | iSpecimen Inc. | 4.49M | 0.97% | 52,228 | 3.35M |
| 50 | XWEL | XWELL, Inc. | 4.48M | -2.88% | 3,852 | 29.52M |
| 51 | BNBX | BNB Plus Corp. | 3.87M | -3.54% | 8,421 | 3.74M |